IN2012DN02804A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02804A IN2012DN02804A IN2804DEN2012A IN2012DN02804A IN 2012DN02804 A IN2012DN02804 A IN 2012DN02804A IN 2804DEN2012 A IN2804DEN2012 A IN 2804DEN2012A IN 2012DN02804 A IN2012DN02804 A IN 2012DN02804A
- Authority
- IN
- India
- Prior art keywords
- moiety
- linkage
- spacer
- adhered
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
- A61K49/0428—Surface-modified nanoparticles, e.g. immuno-nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
- A61K49/1842—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a phosphate or a phosphonate, not being a phospholipid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
- A61K49/186—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA the organic macromolecular compound being polyethyleneglycol [PEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/609,799 US9205155B2 (en) | 2009-10-30 | 2009-10-30 | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
PCT/EP2010/066429 WO2011051422A2 (fr) | 2009-10-30 | 2010-10-29 | Traitement de nanoparticules insolubles dans l'eau à l'aide de conjugués hydrophiles d'acide alpha-hydroxyphosphonique, nanoparticules ainsi modifiées et leur utilisation en tant qu'agents de contraste |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN02804A true IN2012DN02804A (fr) | 2015-07-24 |
Family
ID=43480950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2804DEN2012 IN2012DN02804A (fr) | 2009-10-30 | 2010-10-29 |
Country Status (13)
Country | Link |
---|---|
US (2) | US9205155B2 (fr) |
EP (1) | EP2493512B1 (fr) |
JP (1) | JP5997609B2 (fr) |
KR (1) | KR20120101362A (fr) |
CN (1) | CN102639153B (fr) |
AU (1) | AU2010311437A1 (fr) |
BR (1) | BR112012010113A2 (fr) |
CA (1) | CA2777871A1 (fr) |
ES (1) | ES2720152T3 (fr) |
IN (1) | IN2012DN02804A (fr) |
MX (1) | MX2012005022A (fr) |
RU (1) | RU2012116880A (fr) |
WO (1) | WO2011051422A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986836B2 (en) * | 2009-03-19 | 2015-03-24 | Ohio University | Microspheres and their methods of preparation |
US8920681B2 (en) | 2009-12-30 | 2014-12-30 | Korea University Research And Business Foundation | Electrically conductive polymers with enhanced conductivity |
BR112013013929A2 (pt) * | 2010-12-15 | 2016-09-13 | Gen Electric | composição de nanopartícula, e, processos para fabricar uma composição de nanopartícula e de formação de imagem de diagnóstico |
US8895068B2 (en) | 2010-12-15 | 2014-11-25 | General Electric Company | Nanoparticle composition and associated methods thereof |
US8889103B2 (en) | 2010-12-15 | 2014-11-18 | General Electric Company | Diagnostic agent composition and associated methods thereof |
US9474810B2 (en) * | 2012-03-02 | 2016-10-25 | General Electric Company | Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells |
US9251937B2 (en) * | 2012-06-29 | 2016-02-02 | General Electric Company | Heat stable nanoparticle preparations and associated methods thereof |
CN110799219B (zh) * | 2017-06-28 | 2023-01-06 | 国立研究开发法人理化学研究所 | 纳米颗粒、包含该纳米颗粒的核磁共振成像造影剂、以及配位体化合物 |
US20190001001A1 (en) * | 2017-07-03 | 2019-01-03 | General Electric Company | Drug design for application-dependent payload, controlled pharmacokinetic distribution, and renal clearance |
US11577977B2 (en) * | 2017-09-26 | 2023-02-14 | The Board Of Trustees Of The University Of Arkansas | Composite zero valent iron nanoparticles and applications thereof |
CN110734460B (zh) * | 2019-10-22 | 2022-03-29 | 华南师范大学 | 一类磺酸-膦酸配体的制备及其用途 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5651493A (en) | 1979-10-02 | 1981-05-09 | Yoshitomi Pharmaceut Ind Ltd | Diphosphoglycerol and its preparation |
JPS6043217A (ja) | 1983-08-19 | 1985-03-07 | Toshiba Corp | 磁気記録媒体 |
DE3343586A1 (de) | 1983-11-29 | 1985-06-05 | Herbert Dr. 1000 Berlin Pilgrimm | Verfahren zur entkeimung eines mediums und vorrichtung zur durchfuehrung |
DE3440190A1 (de) | 1984-11-01 | 1986-05-15 | Michel-Kim, Herwig, 1000 Berlin | Verfahren und vorrichtung zur erzeugung von stickstoffduenger und stickstoffangereicherter biomasse aus luft |
DE3443810A1 (de) | 1984-11-28 | 1986-05-28 | Herbert Dr. 1000 Berlin Pilgrimm | Verfahren zur entkeimung eines mediums |
DE3624626A1 (de) | 1986-07-18 | 1988-01-28 | Pilgrimm Herbert | Verfahren zur abtrennung von stoffen aus einem stoffgemisch unter verwendung von magnetischen fluessigkeiten |
DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
DE3709852A1 (de) | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Stabile magnetische fluessigkeitszusammensetzungen und verfahren zu ihrer herstellung und ihre verwendung |
DE4309333A1 (de) | 1993-03-17 | 1994-09-22 | Silica Gel Gmbh | Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben |
DE59403734D1 (de) * | 1993-03-17 | 1997-09-18 | Silica Gel Gmbh | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
WO1996003653A1 (fr) * | 1994-07-27 | 1996-02-08 | Silica Gel Ges.Mbh Absorptionstechnik, Apparatebau | Particules superparamagnetiques, leur procede de production et leur utilisation |
DE19612001A1 (de) * | 1996-03-18 | 1997-09-25 | Silica Gel Gmbh Adsorptions Te | Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung |
DE19726282A1 (de) | 1997-06-20 | 1998-12-24 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern |
DE10016559A1 (de) | 2000-04-03 | 2001-10-18 | Eucro Europe Contract Res Gmbh | System für den Transport von Aktivstoffen in einem biologischen System |
JP2005500436A (ja) | 2001-08-16 | 2005-01-06 | エシロール アテルナジオナール カンパニー ジェネラーレ デ オプティック | 金属ナノ粒子の安定分散液を調製する方法、それにより得られる安定分散液、およびそれを含有するコーティング組成物 |
DE10222481A1 (de) * | 2002-05-22 | 2003-12-04 | Eucro Europe Contract Res Gmbh | Kontrastmittel für die Verwendung in bildgebenden Verfahren |
US6797380B2 (en) | 2002-07-31 | 2004-09-28 | General Electric Company | Nanoparticle having an inorganic core |
DE50213399D1 (de) * | 2002-10-09 | 2009-05-07 | Pilgrimm Helga | Stabilisierte superparamagnetische teilchen |
US7560160B2 (en) * | 2002-11-25 | 2009-07-14 | Materials Modification, Inc. | Multifunctional particulate material, fluid, and composition |
FR2848850B1 (fr) * | 2002-12-20 | 2005-06-24 | Guerbet Sa | Nouvelles compositions de particules magnetiques recouvertes de derives gem-bisphosphonates. |
US20040161435A1 (en) | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
DE10323816A1 (de) * | 2003-05-23 | 2004-12-09 | Basf Ag | Verfahren zur Herstellung von Mischoxiden mit mittleren Durchmessern kleiner als 10 Nanometer |
US20060018835A1 (en) * | 2004-04-02 | 2006-01-26 | General Electric Company | Nanoparticles with inorganic core and methods of using them |
CN100334166C (zh) | 2005-01-26 | 2007-08-29 | 上海大学 | 一种纳米碳酸钙的改性方法 |
US8084275B2 (en) * | 2005-02-08 | 2011-12-27 | Fujifilm Corporation | Magnetic composite body, production method thereof, method for removing substance with mannose on its surface, and method for concentrating substance with mannose on its surface |
KR100746312B1 (ko) * | 2005-03-14 | 2007-08-03 | 한국화학연구원 | 수용성 산화철 나노 입자 및 이의 제조방법 |
WO2006124670A2 (fr) | 2005-05-12 | 2006-11-23 | Georgia Tech Research Corporation | Nanoparticules d'oxyde metallique revetues et procedes de production |
US7767736B2 (en) | 2005-12-05 | 2010-08-03 | 3M Innovative Properties Company | Flame retardant polymer composition |
DE102005059751A1 (de) | 2005-12-09 | 2007-06-14 | Ferropharm Gmbh Forschungslabor | Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie |
ITFI20060006A1 (it) | 2006-01-04 | 2007-07-05 | Colorobbia Italiana Spa | Nanoparticelle funzionalizzate, loro produzione ed uso |
DE102006007888A1 (de) | 2006-02-21 | 2007-08-23 | Degussa Gmbh | Aluminiumoxid enthaltende Dispersion, Zubereitung enthaltend diese Dispersion und ein Melaminharz und mittels dieser Zubereitung hergestelles gehärtetes Produkt |
JP5282031B2 (ja) | 2006-05-15 | 2013-09-04 | ドミトリィ ビー カーポティン | 有機物を含む磁性微粒子 |
FR2904784B1 (fr) * | 2006-08-10 | 2010-09-03 | Surfactis Technologies | Procede de recouvrement de surfaces metalliques et minerales par de monocouches autoassemblees de composes bisphosphoniques et leurs utilisations |
US20080299046A1 (en) | 2006-10-16 | 2008-12-04 | The Trustees Of Columbia University In The City Of New York | Methods for controlling surface functionality of metal oxide nanoparticles, metal oxide nanoparticles having controlled functionality, and uses thereof |
EP2152320A2 (fr) | 2007-04-30 | 2010-02-17 | Intezyne Technologies Incorporated | Agents de contraste encapsulés |
US9072789B2 (en) * | 2007-07-20 | 2015-07-07 | The Trustees Of Princeton University | Nano-particle surface modification |
SG150405A1 (en) | 2007-08-29 | 2009-03-30 | Agency Science Tech & Res | Method of coating a particle |
FR2921838A1 (fr) * | 2007-10-05 | 2009-04-10 | Guerbet Sa | Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile |
KR20090038337A (ko) | 2007-10-15 | 2009-04-20 | 재단법인서울대학교산학협력재단 | 무기계 나노입자를 수계 매질에 분산시키는 생체적합성분산 안정화제 |
JP2011519342A (ja) | 2007-12-13 | 2011-07-07 | アドゥロ バイオテック | リガンド結合温熱療法サセプタおよびその作成方法 |
US20090226376A1 (en) * | 2008-03-05 | 2009-09-10 | General Electric Company | Novel Mixed Ligand Core/Shell Iron Oxide Nanoparticles for Inflammation Imaging |
US8173198B2 (en) | 2008-07-23 | 2012-05-08 | Life Technologies Corporation | Deposition of metal oxides onto surfaces as an immobilization vehicle for carboxylated or phophated particles or polymers |
US20100166664A1 (en) | 2008-12-29 | 2010-07-01 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
JP5651493B2 (ja) | 2010-02-08 | 2015-01-14 | 太平洋セメント株式会社 | 多種アルカリ土類金属窒化物複合体の製造方法 |
-
2009
- 2009-10-30 US US12/609,799 patent/US9205155B2/en active Active
-
2010
- 2010-10-29 CA CA2777871A patent/CA2777871A1/fr not_active Abandoned
- 2010-10-29 EP EP10771742.3A patent/EP2493512B1/fr active Active
- 2010-10-29 WO PCT/EP2010/066429 patent/WO2011051422A2/fr active Application Filing
- 2010-10-29 MX MX2012005022A patent/MX2012005022A/es not_active Application Discontinuation
- 2010-10-29 IN IN2804DEN2012 patent/IN2012DN02804A/en unknown
- 2010-10-29 CN CN201080049469.4A patent/CN102639153B/zh active Active
- 2010-10-29 ES ES10771742T patent/ES2720152T3/es active Active
- 2010-10-29 RU RU2012116880/15A patent/RU2012116880A/ru not_active Application Discontinuation
- 2010-10-29 KR KR1020127010759A patent/KR20120101362A/ko not_active Application Discontinuation
- 2010-10-29 AU AU2010311437A patent/AU2010311437A1/en not_active Abandoned
- 2010-10-29 BR BR112012010113A patent/BR112012010113A2/pt not_active IP Right Cessation
- 2010-10-29 JP JP2012535840A patent/JP5997609B2/ja active Active
-
2015
- 2015-10-21 US US14/919,077 patent/US9827335B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102639153A (zh) | 2012-08-15 |
EP2493512B1 (fr) | 2019-01-23 |
WO2011051422A2 (fr) | 2011-05-05 |
CA2777871A1 (fr) | 2011-05-05 |
JP5997609B2 (ja) | 2016-09-28 |
AU2010311437A1 (en) | 2012-04-12 |
WO2011051422A3 (fr) | 2011-07-21 |
US20110104072A1 (en) | 2011-05-05 |
CN102639153B (zh) | 2017-02-22 |
BR112012010113A2 (pt) | 2019-09-24 |
RU2012116880A (ru) | 2013-12-10 |
US9205155B2 (en) | 2015-12-08 |
US9827335B2 (en) | 2017-11-28 |
ES2720152T3 (es) | 2019-07-18 |
JP2013509381A (ja) | 2013-03-14 |
MX2012005022A (es) | 2012-06-08 |
KR20120101362A (ko) | 2012-09-13 |
US20160038617A1 (en) | 2016-02-11 |
EP2493512A2 (fr) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02804A (fr) | ||
BRPI1014952A2 (pt) | "composição produzida por um microrganismo e composição de biocombustível." | |
IN2012DN02092A (fr) | ||
MX343625B (es) | Composiciones plagicidas. | |
BR112012029917A2 (pt) | composições de nanotransportador com adjuvante desacoplado | |
BRPI0924494A2 (pt) | "refrigerador." | |
EP2334800A4 (fr) | Microorganismes pour la production de 1,4-butanediol | |
TR201901930T4 (tr) | Topraktaki mikrobiyal aktivitenin geliştirilmesine yönelik bir yöntem. | |
WO2011009539A8 (fr) | CONJUGUÉS DE ε-POLYLYSINE ET LEUR UTILISATION | |
BRPI1014207A2 (pt) | "trasmissão." | |
WO2008089397A3 (fr) | Marqueurs du cancer adrb2 | |
BR112013010922A2 (pt) | pó de copolímero de etileno catalisado de cromo | |
BRPI0922279A2 (pt) | "aerogéis híbridos telequélicos". | |
MX2010002656A (es) | Formulaciones y dispositivos para suministro de compuestos a artropodos y microorganismos dentro de artropodos. | |
BRPI1006058A2 (pt) | "fermentação de carboidrato" | |
IT1397136B1 (it) | Macchina per neutralizzare la carica batterica di rifiuti ospedalieri o d'altri rifiuti speciali, per poterli smaltire come rifiuti assimilabili a quelli solidi urbani. | |
BR112012014749A2 (pt) | preservação com biguanida de carbonato de cálcio precipitado | |
WO2009156724A3 (fr) | Nouveaux composés | |
MX2010008668A (es) | Composiciones fungicidas que comprenden 3'-bromo-2,3,4,6'-tetramet oxy-2'-6-dimetilbenzofenona. | |
WO2012004684A3 (fr) | Conjugués aminoglycoside-lipide guanidinylés | |
WO2011029536A3 (fr) | Utilisation de céto-énols cycliques pour lutter contre des bactéries pathogènes chez les végétaux | |
FR2950047B1 (fr) | Station d'epuration a boue activee. | |
UA96476C2 (ru) | Фармацевтические композиции, которые содержат ирбесартан | |
SG163478A1 (en) | Polymer stabilizer | |
MX2011006504A (es) | Composicion de control de enfermedades vegetales, metodo de control de enfermedades vegetales, y nuevo microorganismo. |